BioDelivery Sciences (BDSI) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts BDSI Hot Sheet
Price: $5.59 --0%
Financial Fact:
Net (loss) income: -15.98M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Net (loss) income: -15.98M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
BioDelivery Sciences (NASDAQ: BDSI) reported Q2 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $9.39 million.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- Information Services Group (III) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
